Satisfaction with Cancer Care – Core questionnaire

Patient satisfaction is now recognized as an important indicator of care quality. Measures of patient satisfaction with care can facilitate monitoring initiatives for care improvement over time. The EORTC Quality of Life Group has cross-culturally validated a stand-alone in-patient satisfaction with cancer care questionnaire, the IN-PATSAT32. Advances in cancer care delivery required further development of this questionnaire to assess patients’ perceived quality of the care received across cancer care settings. Phase I to III of this process have been completed, resulting in the EORTC PATSAT-C33 satisfaction with cancer care core questionnaire to assess cancer care delivery as a whole. This questionnaire is currently undergoing phase IV large-scale cross-cultural psychometric assessment. In the present phase IV large-scale psychometric study, the EORTC PATSAT-C33 will be administered to four main groups of patients based on the cancer care settings which they attend, at three subsequent assessment times. We will investigate the cross-cultural applicability and acceptability, scale structure, reliability including test-retest and internal consistency, validity, including construct (known-group comparisons), convergent and divergent validity, responsiveness to change and cross-cultural invariance of psychometric properties. The sample size will be of 500 to ensure balanced patients’ representation across cancer care settings and cultures/geographical areas. Twenty institutions from European as well as Asian and North/South American regions are aiming to participate in the study during around a 25-months data collection period.

Phase I to III of the development of a cancer patient satisfaction questionnaire and outpatient module have been completed.

Current status:

Phase IV, cross-cultural large-scale field testing psychometric and prospective study is ongoing.

Phase IV accrual is planned up to November 2023.

Patient satisfaction is now recognized as an important indicator of care quality. Measures of patient satisfaction with care can facilitate monitoring initiatives for care improvement over time. The EORTC Quality of Life Group has cross-culturally validated a stand-alone in-patient satisfaction with cancer care questionnaire. Advances in cancer care delivery required further development of this questionnaire to assess patients’ perceived quality of the care received across hospital cancer settings. The first phases of this process have been completed. The final phase is ongoing. It consists in a large-scale, cross-cultural evaluation of the measurement properties of this questionnaire. The sample size will be of 500 to ensure balanced patients’ representation across cancer care settings and cultures/geographical areas. Twenty institutions from European as well as Asian and North/South American regions are aiming to participate in the study during around a 25-months data collection period.